File Download
  • No File Attached
 
 
Patent History
 
Supplementary

Granted Patent: Pharmaceutical Composition Having A Ruthenium Oxalato Compound And Method Of Using The Same
  • Basic View
  • Metadata View
  • XML View
TitlePharmaceutical Composition Having A Ruthenium Oxalato Compound And Method Of Using The Same
 
Granted PatentEP 1940385
 
Granted Date2012-02-01
 
Priority Date2006-09-28 PCT/CN2006002547
2005-10-24 US 11/256175
 
InventorsChe, CM
Sun, RWY
Wong, Lai Ming Ella
 
Issue Date2012
 
CitationEP Patent 1940385. European Patent Office (EPO), Escapenet, 2012 [How to Cite?]
 
AbstractA Pharmaceutical Composition Comprising One Or More Of The Following Ruthenium Oxalate Compounds Formulae (I , Ii , Iii , And Iv) As An Active Ingredient . The Pharmaceutical Composition Can Be Used For The Treatment Of Viral-Infected Patients Or Prophylactic Treatment Of Patients At Risk From Viral Infection .
 
ReferencesGB 1109890 (A) 1968-04-18

XP 008080618

XP 003012198

XP 003012199
 
DC FieldValue
dc.contributor.inventorChe, CM
 
dc.contributor.inventorSun, RWY
 
dc.contributor.inventorWong, Lai Ming Ella
 
dc.date.accessioned2012-11-02T06:19:23Z
 
patents.date.application2006-09-28
 
dc.date.available2012-11-02T06:19:23Z
 
patents.date.granted2012-02-01
 
dc.date.issued2012
 
patents.date.priority2006-09-28 PCT/CN2006002547
 
patents.date.priority2005-10-24 US 11/256175
 
patents.date.publication2012-09-06
 
dc.description.abstractA Pharmaceutical Composition Comprising One Or More Of The Following Ruthenium Oxalate Compounds Formulae (I , Ii , Iii , And Iv) As An Active Ingredient . The Pharmaceutical Composition Can Be Used For The Treatment Of Viral-Infected Patients Or Prophylactic Treatment Of Patients At Risk From Viral Infection .
 
patents.description.assigneeUniv Hong Kong [Cn]
 
patents.description.ccEP
 
patents.description.countryEuropean Patent Office
 
patents.description.kindB1
 
patents.identifier.applicationEP 20060791135
 
dc.identifier.citationEP Patent 1940385. European Patent Office (EPO), Escapenet, 2012 [How to Cite?]
 
patents.identifier.grantedEP 1940385
 
patents.identifier.hkutechidChm-2005-00204
 
patents.identifier.publicationUS 20120227136
 
dc.identifier.urihttp://hdl.handle.net/10722/173789
 
patents.relation.familyAT 543495 (T) 2012-02-15
 
patents.relation.familyCN 101378748 (A) 2009-03-04
 
patents.relation.familyEP 1940385 (A1) 2008-07-09
 
patents.relation.familyUS 2007105952 (A1) 2007-05-10
 
patents.relation.familyUS 7648977 (B2) 2010-01-19
 
patents.relation.familyWO 2007048311 (A1) 2007-05-03
 
dc.relation.referencesGB 1109890 (A) 1968-04-18
 
dc.relation.referencesXP 008080618
 
dc.relation.referencesXP 003012198
 
dc.relation.referencesXP 003012199
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
 
dc.titlePharmaceutical Composition Having A Ruthenium Oxalato Compound And Method Of Using The Same
 
dc.typePatent
 
patents.typePatent_granted
 
<?xml encoding="utf-8" version="1.0"?>
<item><date.accessioned>2012-11-02T06:19:23Z</date.accessioned>
<date.available>2012-11-02T06:19:23Z</date.available>
<date.issued>2012-11-02</date.issued>
<identifier.citation>EP Patent 1940385. European Patent Office (EPO), Escapenet, 2012</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/173789</identifier.uri>
<description.abstract>A Pharmaceutical Composition Comprising One Or More Of The Following Ruthenium Oxalate Compounds Formulae (I , Ii , Iii , And Iv) As An Active Ingredient . The Pharmaceutical Composition Can Be Used For The Treatment Of Viral-Infected Patients Or Prophylactic Treatment Of Patients At Risk From Viral Infection .</description.abstract>
<rights>Creative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents</rights>
<title>Pharmaceutical Composition Having A Ruthenium Oxalato Compound And Method Of Using The Same</title>
<type>Patent</type>
<contributor.inventor>Che, CM</contributor.inventor>
<contributor.inventor>Sun, RWY</contributor.inventor>
<contributor.inventor>Wong, Lai Ming Ella</contributor.inventor>
<relation.references>GB 1109890 (A)  1968-04-18</relation.references>
<relation.references>XP  008080618</relation.references>
<relation.references>XP  003012198</relation.references>
<relation.references>XP  003012199</relation.references>
<patents.identifier.application>EP 20060791135</patents.identifier.application>
<patents.identifier.granted>EP 1940385</patents.identifier.granted>
<patents.description.assignee>Univ Hong Kong [Cn]</patents.description.assignee>
<patents.description.country>European Patent Office</patents.description.country>
<patents.date.publication>2012-09-06</patents.date.publication>
<patents.date.granted>2012-02-01</patents.date.granted>
<patents.identifier.hkutechid>Chm-2005-00204</patents.identifier.hkutechid>
<patents.date.application>2006-09-28</patents.date.application>
<patents.date.priority>2006-09-28 PCT/CN2006002547</patents.date.priority>
<patents.date.priority>2005-10-24 US 11/256175</patents.date.priority>
<patents.description.cc>EP</patents.description.cc>
<patents.identifier.publication>US 20120227136</patents.identifier.publication>
<patents.relation.family>AT 543495 (T)  2012-02-15</patents.relation.family>
<patents.relation.family>CN 101378748 (A)  2009-03-04</patents.relation.family>
<patents.relation.family>EP 1940385 (A1)  2008-07-09</patents.relation.family>
<patents.relation.family>US 2007105952 (A1)  2007-05-10</patents.relation.family>
<patents.relation.family>US 7648977 (B2)  2010-01-19</patents.relation.family>
<patents.relation.family>WO 2007048311 (A1)  2007-05-03</patents.relation.family>
<patents.description.kind>B1</patents.description.kind>
<patents.type>Patent_granted</patents.type>
</item>